TNI-NX Trademark

Trademark Overview

On Thursday, March 1, 2018, a trademark application was filed for TNI-NX with the United States Patent and Trademark Office. The USPTO has given the TNI-NX trademark a serial number of 87816919. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 16, 2022. This trademark is owned by Abbott Point of Care Inc.. The TNI-NX trademark is filed in the Pharmaceutical Products category with the following description:

Cartridges sold prefilled with medical diagnostic reagents for use in in vitro diagnostic testing; cartridges sold prefilled with medical diagnostic reagents; diagnostic kits consisting of medical diagnostic reagents and assays for measuring troponin levels; medical diagnostic test media in the form of assays for measuring the in vitro cardiac troponin I in whole blood or plasma; medical diagnostic tests comprised of medical diagnostic reagents within an analytical system for diagnosing myocardial infarction; medical diagnostic tests comprised of medical diagnostic reagents within an analytical system to aid in risk stratification of patients with acute coronary syndromes with respect to relative risk of mortality
tni-nx

General Information

Serial Number87816919
Word MarkTNI-NX
Filing DateThursday, March 1, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 16, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 12, 2019

Trademark Statements

Goods and ServicesCartridges sold prefilled with medical diagnostic reagents for use in in vitro diagnostic testing; cartridges sold prefilled with medical diagnostic reagents; diagnostic kits consisting of medical diagnostic reagents and assays for measuring troponin levels; medical diagnostic test media in the form of assays for measuring the in vitro cardiac troponin I in whole blood or plasma; medical diagnostic tests comprised of medical diagnostic reagents within an analytical system for diagnosing myocardial infarction; medical diagnostic tests comprised of medical diagnostic reagents within an analytical system to aid in risk stratification of patients with acute coronary syndromes with respect to relative risk of mortality

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 8, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAbbott Point of Care Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540
Party NameAbbott Point of Care Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540

Trademark Events

Event DateEvent Description
Monday, May 16, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 16, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 19, 2021SOU EXTENSION 5 GRANTED
Monday, October 11, 2021SOU EXTENSION 5 FILED
Monday, October 18, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 11, 2021TEAS EXTENSION RECEIVED
Thursday, May 27, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 27, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, May 27, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 27, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, February 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 25, 2021SOU EXTENSION 4 GRANTED
Thursday, February 25, 2021SOU EXTENSION 4 FILED
Thursday, February 25, 2021TEAS EXTENSION RECEIVED
Tuesday, September 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 4, 2020SOU EXTENSION 3 GRANTED
Friday, September 4, 2020SOU EXTENSION 3 FILED
Friday, September 4, 2020TEAS EXTENSION RECEIVED
Tuesday, March 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 13, 2020SOU EXTENSION 2 GRANTED
Friday, March 13, 2020SOU EXTENSION 2 FILED
Friday, March 13, 2020TEAS EXTENSION RECEIVED
Wednesday, September 11, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 9, 2019SOU EXTENSION 1 GRANTED
Monday, September 9, 2019SOU EXTENSION 1 FILED
Monday, September 9, 2019TEAS EXTENSION RECEIVED
Tuesday, April 9, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 12, 2019PUBLISHED FOR OPPOSITION
Wednesday, January 23, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 21, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 13, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 13, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 13, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, June 16, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, June 16, 2018NON-FINAL ACTION E-MAILED
Saturday, June 16, 2018NON-FINAL ACTION WRITTEN
Wednesday, June 13, 2018ASSIGNED TO EXAMINER
Thursday, March 8, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, March 5, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

diagnostic medical reagents tests risk cartridges comprised within system measuring